Atlas FDA

Bio-Rad Variant II Turbo Link Hemoglobin Testing System, including Hemoglobin A, Program Reorder Pack 1600 Tests, Progra

FDA device recall Z-1259-2011 · posted 2011-02-15 · Terminated

Recall details

Recalling firm
Bio-Rad Laboratories Inc
Reason for recall
The results from the blood device had the occurrence of some ramping baselines on their chromatograms. The ramping baseline can affect quantitation of the blood results.
Action taken
The firm, Bio-Rad Laboratories, Inc., sent an "URGENT: MEDICAL DEVICE CORRECTION" letter dated February 5, 2010, to all customers and letter dated February 16, 2010 to subsidiaries via Fed-Ex or by fax. The letter described the product, problem and action to be taken by the customers. The customers were instructed to review there chromatograms form the lots listed and compare them to what documented; follow the noted instructions; destroy reorder packs from the affected lots if a ramping baseline issue is observed, and complete and return the attached CUSTOMER MEDICAL DEVICE CORRECTION RESPONSE FORM via fax to (510) 741-3954, attention: Bio-Rad CSD Regulatory Affairs Department. If you have any questions, please contact your regional Bio-Rad Office or (510)724-7000.
Root cause
Nonconforming Material/Component
Status
Terminated
Product code
LCP
Quantity affected
27
Distribution
Worldwide distribution: USA including states of: OH, MN, SC and VA; and country including: Japan.
Date initiated
2010-02-19
Date posted
2011-02-15
Date terminated
2011-03-03
Location
Hercules, CA

Monitor recalls programmatically

Recalls and clearances share one API, with change alerts when new recalls post.

Related 510(k) clearances

RecordFirmDate
VARIANT II TURBO LINK HEMOGLOBIN A1C PROGRAM, AND VARIANT II TURBO LINK HEMOGLOBIN TESTING WITH MODEL, 270-2716, (K070819)Bio-Rad Laboratories Inc., Clinical Systems Divisi2007-06-25